CNS Prophylaxis

The most demonstrative one is patient with testicular lymphoma, and we tend to use IV, high dose metrotrexate at the end after completing our job. Then there is this patient with higher risk, and I will say it's a patient-per-patient decision. For particular adrenal renal, advanced IPI and high LDH and advanced age. We need to generate more data in this field,. maybe it will be is it confirmed in some patients or abandoned?